Underlying Cardiomyopathy in Patients With ST-Segment Elevation in the Right Precordial Leads(Clinical Investigation)

Hyungseop Kim(Keimyung University Dongsan Medical Center), Hun Sik Park(Kyungpook National University Hospital), Yongkeun Cho(Kyungpook National University Hospital), Yonghwi Park(Kyungpook National University), Hyun‐Jae Kang(Daegu Fatima Hospital), Deuk-Young Nah(University of Ulsan), Dong Heon Yang(Kyungpook National University Hospital), Tae In Park(Kyungpook National University Hospital), Hyunsang Lee(Gumi University)
Japanese Circulation Journal-english Edition
May 20, 2006
Cited by 1

Related Papers

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
|The Lancet|2018|372
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
|Circulation|2013|281